Поисковый запрос: <.>S=ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ СПЕЦИФИЧЕСКИЙ АНТИГЕН -- Prostate-Specific Antigen<.> |
Общее количество найденных документов : 106
Показаны документы с 1 по 20 |
|
1.
| Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy./T.M. Soergel, M.O. Koch, R.S. Foster et al. // JOURNAL of UROLOGY. -New York, 2001. т.Vol.166,N N6.-С.2198-2201
|
2.
| Adverse prognostic significance of capsular incision with radical retropubic prostatectomy/M.D. Shuford, M.S. Cookson, S.S. Chang et al. // JOURNAL of UROLOGY. -New York, 2004. т.Vol.172,N N1.-С.119-123
|
3.
| Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening /J.W. Moul, L. Sun, J.M. Hotaling et al. // JOURNAL of UROLOGY. -New York, 2007. т.Vol.177,N N2.-С.499-504
|
4.
| Ankerst D.P. Understanding mixed messages about prostate specific antigen: Biases in the evaluation of cancer biomarkers/D.P. Ankerst, I.M. Thompson // JOURNAL of UROLOGY. -New York, 2007. т.Vol.177,N N2.-С.426-427
|
5.
| Benson M.C. Prostate specific antigen screening/M.C. Benson, J. McKiernan // JOURNAL of UROLOGY. -New York, 2007. т.Vol.177,N N4.-С.1225-1226
|
6.
| Biochemical failure in men following radical retropubic prostatectomy: Impact of surgical margin status and location /J.A. Pettus, Ch.J. Weight, C.J. Thompson et al. // JOURNAL of UROLOGY. -New York, 2004. т.Vol.172,N N1.-С.129-132
|
7.
| Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center/M. E. Nielsen, M. Han, L. Mangold et al. // JOURNAL of UROLOGY. -New York, 2006. т.Vol.176,N N2.-С.515-519
|
8.
| Bruno II J.J. Influence of prostate volume and percent free prostate specific antigen on prostate cancer detection in men with a total specific antigen of 2.6 to 10.0 ng/ml/J.J. Bruno II, N.A. Armenakas, J.A. Fraccia // JOURNAL of UROLOGY. -New York, 2007. т.Vol.177,N N5.-С.1741-1744
|
9.
| Can prostate specific antigen derivatives and pathological parameters predict significant chenge in expectant management criteria for prostate cancer?/M.A. Khan, H.B. Carter, J.I. Epstein et al. // JOURNAL of UROLOGY. -New York, 2003. т.Vol.170,N N6, pt.1 of 2.-С.2274 - 2278
|
10.
| Changing nature of high risk patients undergoing radical prostatectomy/Ch.J. Kane, J.C. Presti Jr., Ch.L. Amling et al. // JOURNAL of UROLOGY. -New York, 2007. т.Vol.177,N N1.-С.113-117
|
11.
| Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection/E.E. Kline, E.G. Treat, T.A. Averna et al. // JOURNAL of UROLOGY. -New York, 2006. т.Vol.176,N N5.-С.2274-2279
|
12.
| Clinical use of monoclonal antibody Hu J591 therapy: targeting prostate specific membrane antigen/D.M. Nanus, M.I. Milowsky, L. Kostakoglu et al. // JOURNAL of UROLOGY. -New York, 2003. т.Vol.170,N N6 pt.2 of 2 .-С.S84 - S89
|
13.
| Clinical value of longitudinal free-to-total prostate specific antigen ratio slope to diagnosis of prostate cancer/H. Zhu, K.A. Roehl, J.A.V. Antenor, W.J. Catalona // JOURNAL of UROLOGY. -New York, 2004. т.Vol.171,N N2 pt. 1.-С.661-663
|
14.
| Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in hispanic-american and white men/J.S. Lam, K. Cheung, M.C. Benson, Goluboff E.T. // JOURNAL of UROLOGY. -New York, 2003. т.Vol.170,N N2 pt.1 of 2.-С.451-456
|
15.
| Continuing controversy over monitoring men with localized prostate cancer: A systematic review of programs in the prostate specific antigen era/R.M. Martin, D. Gunnell, F. Hamdy et al. // JOURNAL of UROLOGY. -New York, 2006. т.Vol.176,N N2.-С.439-449
|
16.
| D'Amico A. V. Prostate cancer prevention and finasteride/A. V. D'Amico, M. J. Barry // JOURNAL of UROLOGY. -New York, 2006. т.Vol.176,N N5.-С.2010-2013
|
17.
| Daskivich T. J. Prostate specific antigen doubling time calculation: Not as easy as 1, 2, 4/T. J. Daskivich, M. M. Regan, W. K. Oh // JOURNAL of UROLOGY. -New York, 2006. т.Vol.176,N N5.-С.1927-1937
|
18.
| Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer/S.J. Freedland, Ch.J. Kane, Ch.L. Amling et al. // JOURNAL of UROLOGY. -New York, 2006. т.Vol.175,N N4.-С.1298-1303
|
19.
| Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: Natural history and prognostic significance/Sh. Sengupta, C. M. Christensen, H. Zincke et al. // JOURNAL of UROLOGY. -New York, 2006. т.Vol.176,N N2.-С.559-563
|
20.
| Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era/A.V. D'amico , K. Cote , M. Loffredo et al. // JOURNAL of UROLOGY. -New York, 2003. т.Vol.170,N N6 pt.2 of 2 .-С.S42-47
|
|
|
|
Періодичних видань
Стандартный